Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

BACKGROUND: New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence. We previously demonstrated the upregulation of leucine-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Andersen, John D, Boylan, Kristin LM, Jemmerson, Ronald, Geller, Melissa A, Misemer, Benjamin, Harrington, Katherine M, Weivoda, Starchild, Witthuhn, Bruce A, Argenta, Peter, Vogel, Rachel Isaksson, Skubitz, Amy PN
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949730/
https://ncbi.nlm.nih.gov/pubmed/20831812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-3-21
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars